microneedle drug delivery systems market, estimated at around USD 6.22 billion in 2024, is set to grow strongly over the next decade, driven by rising demand for minimally invasive drug administration and increasing burden of chronic diseases. Innovations in microneedle design and materials, coupled with patient preference for needle-free systems, are fueling this surge. To delve deeper...